Grass pollen-derived allergy immunotherapeutic (ASIT biotech)

N/A

Report date: 2022/07/19 20:00:45

Base Information

Drug NameGrass pollen-derived allergy immunotherapeutic (ASIT biotech)
Drug Alias NameABT-011
ClassificationBiologics > Antigen > Allergen extract
Mechanisms of ActionImmunosuppressants
TargetsNot applicable
Therapy Area/IndicationsRhinitis, Allergic, SeasonalRhinitis, Allergic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumItalyGermany +[6] 
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAsit Biotech Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiotech Tools Sa
Active IndicationsN/A
Inactive IndicationsRhinitis, Allergic, SeasonalRhinitis, Allergic

Other Information

ATC CodeN/A
Related LinksN/A